1. Home
  2. POM vs IXHL Comparison

POM vs IXHL Comparison

Compare POM & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.31

Market Cap

47.2M

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.13

Market Cap

45.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
POM
IXHL
Founded
2015
2001
Country
China
Australia
Employees
N/A
N/A
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
45.0M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
POM
IXHL
Price
$0.31
$3.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
629.7K
468.7K
Earning Date
05-03-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.11
52 Week High
$6.43
$6.39

Technical Indicators

Market Signals
Indicator
POM
IXHL
Relative Strength Index (RSI) 52.54 54.62
Support Level $0.28 $0.34
Resistance Level $0.43 $3.68
Average True Range (ATR) 0.04 0.33
MACD 0.00 -0.10
Stochastic Oscillator 68.97 53.36

Price Performance

Historical Comparison
POM
IXHL

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: